Articles published by Apimeds Pharmaceuticals US, Inc.

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

November 10, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Tickers APUS

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist College of Business

October 14, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Tickers APUS

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

September 15, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Tickers APUS

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

September 11, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Tickers APUS

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

August 25, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Tickers APUS

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

July 15, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Tickers APUS

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

May 12, 2025

From Apimeds Pharmaceuticals US, Inc.

Via GlobeNewswire

Tickers APUS

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

May 08, 2025

From Apimeds Pharmaceuticals US, Inc.

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.